Tumor testing in men with prostate cancer to predict for germline DNA-damage repair mutations

MLA

Karen Cadoo, et al. “Tumor Testing in Men with Prostate Cancer to Predict for Germline DNA-Damage Repair Mutations.” Journal of Clinical Oncology, vol. 37, Mar. 2019, p. 229. EBSCOhost, https://doi.org/10.1200/jco.2019.37.7_suppl.229.

APA

Karen Cadoo, Daniel C. Danila, David B. Solit, Zsofia K. Stadler, Karen A. Autio, Lewis J. Kampel, Michael Francis Walsh, Maria I. Carlo, Yelena Kemel, Kelsey Breen, Mark E. Robson, Howard I. Scher, Dana E. Rathkopf, Susan F. Slovin, Michael J. Morris, Kenneth Offit, & Wassim Abida. (2019). Tumor testing in men with prostate cancer to predict for germline DNA-damage repair mutations. Journal of Clinical Oncology, 37, 229. https://doi.org/10.1200/jco.2019.37.7_suppl.229

Chicago

Karen Cadoo, Daniel C. Danila, David B. Solit, Zsofia K. Stadler, Karen A. Autio, Lewis J. Kampel, Michael Francis Walsh, et al. 2019. “Tumor Testing in Men with Prostate Cancer to Predict for Germline DNA-Damage Repair Mutations.” Journal of Clinical Oncology 37 (March): 229. doi:10.1200/jco.2019.37.7_suppl.229.